bdf 9148 has been researched along with ouabain in 10 studies
| Studies (bdf 9148) | Trials (bdf 9148) | Recent Studies (post-2010) (bdf 9148) | Studies (ouabain) | Trials (ouabain) | Recent Studies (post-2010) (ouabain) |
|---|---|---|---|---|---|
| 39 | 0 | 1 | 16,357 | 72 | 747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhm, M; Erdmann, E; La Rosée, K; Schmidt, U; Schulz, C; Schwinger, RH | 1 |
| Böhm, M; Erdmann, E; La Rosée, K; Mittmann, C; Schwinger, RH | 1 |
| Böhm, M; Eissner, HJ; Kreuzer, E; Müller-Ehmsen, J; Reichart, B; Schmidt, U; Schwinger, RH; Stäblein, A; Uberfuhr, P; Uhlmann, R | 1 |
| Erdmann, E; Frank, K; Martin-Vasallo, P; McDonough, AA; Müller-Ehmsen, J; Pressley, TA; Schwinger, RH; Wang, J; Xiang, A | 1 |
| Bavendiek, U; Brixius, K; Erdmann, E; Frank, K; Gross, A; Müller-Ehmsen, J; Pietsch, M; Reuter, H; Schwinger, RH | 1 |
| Brixius, K; Frank, K; Müller-Ehmsen, J; Schwinger, RH | 1 |
| Bavendiek, U; Brixius, K; Müller-Ehmsen, J; Münch, G; Schwinger, RH; Zobel, C | 1 |
| Müller-Ehmsen, J; Näbauer, M; Schwinger, RH | 1 |
| Böhm, M; Flesch, M; Häuseler, C; Hellige, G; Pfahlberg, A; Schiffmann, H | 1 |
| Hackmann, F; Hellige, G; Hoebel, D; Luers, F; Pfahlberg, A; Rizouli, V; Schiffmann, H | 1 |
10 other study(ies) available for bdf 9148 and ouabain
| Article | Year |
|---|---|
Na(+)-channel activators increase cardiac glycoside sensitivity in failing human myocardium.
Topics: Adult; Azetidines; Cardiomyopathy, Dilated; Cardiotonic Agents; Drug Interactions; Female; Heart Transplantation; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Myocardium; Ouabain; Papillary Muscles; Sodium Channels | 1992 |
Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
Topics: Adult; Azetidines; Cardiomyopathy, Dilated; Cardiotonic Agents; Cell Membrane; Dose-Response Relationship, Drug; Female; Heart; Humans; In Vitro Techniques; Isoproterenol; Kinetics; Male; Middle Aged; Molecular Structure; Myocardial Contraction; Myocardium; Ouabain; Piperazines; Sodium Channels | 1991 |
Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart.
Topics: Adult; Azetidines; Calcium; Cardiac Output, Low; Cardiotonic Agents; Cyclic AMP; Electric Stimulation; Female; Heart; Humans; Isometric Contraction; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Ouabain | 1993 |
Regional expression of sodium pump subunits isoforms and Na+-Ca++ exchanger in the human heart.
Topics: Adult; Azetidines; Biological Transport; Calcium; Carrier Proteins; Female; Heart Atria; Heart Septum; Heart Ventricles; Humans; Immunoblotting; Isoenzymes; Male; Middle Aged; Myocardium; Ouabain; Potassium; Sodium; Sodium-Calcium Exchanger; Sodium-Potassium-Exchanging ATPase; Tissue Distribution; Tissue Donors | 1996 |
Altered inotropism in the failing human myocardium.
Topics: Adrenergic beta-Agonists; Azetidines; Calcium; Calcium-Binding Proteins; Calcium-Transporting ATPases; Cardiotonic Agents; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Heart Failure; Humans; In Vitro Techniques; Indoles; Isoproterenol; Myocardial Contraction; Myocardium; Ouabain; Sarcoplasmic Reticulum; Sodium | 1996 |
Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
Topics: Adrenergic beta-Agonists; Antiporters; Azetidines; Calcium; Cardiotonic Agents; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Heart Failure; Heart Transplantation; Humans; Isoproterenol; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Smooth, Vascular; Myocardial Contraction; Ouabain; Papillary Muscles; Sodium; Sodium-Calcium Exchanger; Sodium-Potassium-Exchanging ATPase | 1997 |
Effect of inotropic interventions on the force-frequency relation in the human heart.
Topics: Adrenergic beta-Agonists; Azetidines; Biomechanical Phenomena; Cardiac Output, Low; Cardiotonic Agents; Cyclic AMP; Drug Evaluation, Preclinical; Heart Rate; Humans; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Ouabain; Papillary Muscles | 1998 |
Na+-channel modulating effect of the inotropic compound S(-)BDF 9196 in human myocardium.
Topics: Azetidines; Cardiotonic Agents; Cyclic AMP; Enzyme Inhibitors; Heart; Humans; In Vitro Techniques; Myocardial Contraction; Myocardium; Ouabain; Papillary Muscles; Sodium Channels; Sodium-Potassium-Exchanging ATPase; Stereoisomerism; Ventricular Function, Left | 1999 |
Effects of different inotropic interventions on myocardial function in the developing rabbit heart.
Topics: Adrenergic beta-Agonists; Aging; Animals; Animals, Newborn; Azetidines; Calcium; Calcium-Transporting ATPases; Cardiotonic Agents; Enzyme Inhibitors; Female; Gene Expression; Heart; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Ouabain; Rabbits; Sarcoplasmic Reticulum; Sodium-Calcium Exchanger; Ventricular Pressure | 2002 |
Na(+)-channel modulation, a new principle of inotropic intervention: effects on hemodynamic and myocardial energetics in the immature rabbit heart.
Topics: Age Factors; Animals; Animals, Newborn; Azetidines; Cardiotonic Agents; Coronary Circulation; Cyclic AMP; Enoximone; Female; Isoproterenol; Models, Cardiovascular; Myocardial Contraction; Myocardium; Ouabain; Oxygen Consumption; Pregnancy; Rabbits; Sodium Channels | 2003 |